Cargando…
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform
According to the World Health Organization, more than 1 billion people are at risk of or are affected by neglected tropical diseases. Examples of such diseases include trypanosomiasis, which causes sleeping sickness; leishmaniasis; and Chagas disease, all of which are prevalent in Africa, South Amer...
Ejemplares similares
-
Multitarget, Selective
Compound Design Yields Potent
Inhibitors of a Kinetoplastid Pteridine Reductase 1
por: Pöhner, Ina, et al.
Publicado: (2022) -
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery
por: Linciano, Pasquale, et al.
Publicado: (2017) -
Design, Synthesis and Antiparasitic Evaluation of Click Phospholipids
por: Magoulas, George E., et al.
Publicado: (2021) -
A SARS-CoV-2 cytopathicity dataset generated by high-content screening of a large drug repurposing collection
por: Ellinger, Bernhard, et al.
Publicado: (2021) -
High-Throughput
Phenotypic Screening and Machine Learning
Methods Enabled the Selection of Broad-Spectrum Low-Toxicity Antitrypanosomatidic
Agents
por: Linciano, Pasquale, et al.
Publicado: (2023)